Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets

Himisha Beltran; David S. Rickman; Kyung Park; Sung Suk Chae; Andrea Sboner; Theresa Y. MacDonald; Yuwei Wang; Karen L. Sheikh; Stéphane Terry; Scott T. Tagawa; Rajiv Dhir; Joel B. Nelson; Alexandre de la Taille; Yves Allory; Mark Gerstein; Sven Perner; Kenneth J. Pienta; Arul M. Chinnaiyan; Yuzhuo Wang; Colin C. Collins; Martin Gleave; Francesca Demichelis; David M. Nanus; Mark A. Rubin

doi:10.1158/2159-8290.cd-11-0130

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

We report on the largest in-depth molecular analysis of NEPC and provide new insight into molecular events involved in the progression of prostate cancer.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Beltran et al. (2011) studied this question.

synapsesocial.com/papers/69daccc24e9a02dbaa684963 https://doi.org/10.1158/2159-8290.cd-11-0130

View Full Paper

Ask AI

Bookmark

Share

Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets

Ask about this paper

Abstract

Discussion

Cite This Study

Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading